 |
|
Current Results of Surgical Therapy for Chronic Mesenteric Ischemia
John Moawad, MD;
James F. McKinsey, MD;
Charles W. Wyble, MD;
Hisham S. Bassiouny, MD;
Lewis B. Schwartz, MD;
Bruce L. Gewertz, MD
Arch Surg. 1997;132(6):613-619.
Abstract
| |
Background
Although recognition of chronic mesenteric ischemia has increased in recent years, this disorder has continued to present diagnostic and therapeutic challenges.
Objective
To examine the modern results of surgical revascularization for chronic mesenteric ischemia.
Design
Retrospective review.
Setting
University medical center.
Patients
The management of 24 consecutive patients (mean±SEM age, 58±3 years; 5 men, 19 women) who were undergoing surgical treatment of chronic mesenteric ischemia between 1986 and 1996 was reviewed.
Intervention
Surgical mesenteric revascularization.
Main Outcome Measures
Postoperative course, long-term graft patency rate, and long-term symptom-free survival rate.
Results
The most frequent presenting symptoms were postprandial abdominal pain (18 patients [75%]) and weight loss (14 patients [58%]). Less specific complaints included nausea and vomiting (8 patients [33%]), diarrhea (7 patients [29%]), and constipation (4 patients [17%]). Atherosclerotic risk factors were common, including tobacco use (20 patients [83%]), coronary artery disease (10 patients [42%]), and hypertension (10 patients [42%]). The cause was identified as atherosclerosis in 21 patients, median arcuate ligament compression in 2 patients who were monozygotic twins, and Takayasu arteritis in 1 patient. Lesions were localized to all 3 major visceral vessels (celiac artery, superior mesenteric artery [SMA], and inferior mesenteric artery) in 8 patients, celiac artery and SMA in 13, SMA alone in 2, and SMA and inferior mesenteric artery in 1. Seventeen patients underwent antegrade reconstructions from the supraceliac aorta to the SMA and/or celiac artery; 7 patients underwent revascularization by use of a retrograde bypass that originated from the infrarenal aorta or a prosthetic graft. There were no perioperative deaths although 1 patient died in the hospital 6 weeks after early graft failure and sepsis (overall in-hospital mortality, 4%). Follow-up ranged from 3 months to 10 years (median, 2.4years). The mean±SEM 5-year primary graft patency rate, as objectively documented by use of contrast angiography or duplex scanning in 19 of 24 patients, was 78%±11%. Primary failure was documented in 3 patients (at 3 weeks, 5 months, and 7 months). Two patients required a thrombectomy; 1 of these patients subsequently died of an intestinal infarction. The mean±SEM 5-year survival rate by use of life-table analysis was 71%±11%. No patient with a patent graft experienced a symptomatic recurrence.
Conclusions
Chronic mesenteric ischemia is usually a manifestation of advanced systemic atherosclerosis. Symptoms almost always reflect midgut ischemia in the distribution of the SMA. An antegrade bypass from the supraceliac aorta can be performed with acceptable operative morbidity and is currently the preferred reconstructive technique. Surgical revascularization affords long-term symptom-free survival in a majority of patients with chronic mesenteric ischemia.
Arch Surg. 1997;132:613-619
Author Affiliations
From the Section of Vascular Surgery, Department of Surgery, University of Chicago, Chicago, Ill.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
MDCT Angiography of Mesenteric Bypass Surgery for the Treatment of Chronic Mesenteric Ischemia
Lopera et al.
Am. J. Roentgenol. 2009;193:1439-1445.
ABSTRACT
| FULL TEXT
ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation
Hirsch et al.
J Am Coll Cardiol 2006;47:1239-1312.
FULL TEXT
Mesenteric Ischemia
Ujiki and Kibbe
PERSPECT VASC SURG ENDOVASC THER 2005;17:309-318.
ABSTRACT
Chronic Visceral Ischemia: Symptom-Free Survival After Open Surgical Repair
English et al.
VASC ENDOVASCULAR SURG 2004;38:493-503.
ABSTRACT
Type B Dissection Complicated with Subacute Visceral Ischemia
Yamashiro et al.
Asian Cardiovasc. Thorac. Ann. 2004;12:162-164.
ABSTRACT
| FULL TEXT
Diagnosis and management of intestinal ischaemic disorders
Sreenarasimhaiah
BMJ 2003;326:1372-1376.
FULL TEXT
Mesenteric arterial ischaemia: diagnosis and therapeutic options
Cleveland et al.
Vasc Med 2002;7:311-321.
ABSTRACT
Recent Advances in Peripheral Angioplasty and Stenting
Faries et al.
ANGIOLOGY 2002;53:617-626.
ABSTRACT
Transaortc Endarterectomy for Primary Mesenteric Revascularization
Lau et al.
VASC ENDOVASCULAR SURG 2002;36:335-341.
ABSTRACT
Multi-Detector Row CT of Mesenteric Ischemia: Can It Be Done?
Horton and Fishman
RadioGraphics 2001;21:1463-1473.
ABSTRACT
| FULL TEXT
Mesenteric Revascularization in a Contaminated Abdomen: A Case Report
Young et al.
VASC ENDOVASCULAR SURG 2001;35:415-418.
ABSTRACT
|
